Indexed with PubMed and Science Citation Index (E) 
Users online: 5749 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (75 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded150    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

Year : 2003  |  Volume : 69  |  Issue : 6  |  Page : 428-429

Utility of MycoDot test in the diagnosis of cutaneous tuberculosis

Department of Pathology, Rajah Muthiah Medical College, Annamalai University, Annamalai Nagar, Chidambaram

Correspondence Address:
L., B3, RSA Complex, Annamalai University, Annamalai Nagar, Chidambaram - 608002

How to cite this article:
Rao L, Padmavathy L. Utility of MycoDot test in the diagnosis of cutaneous tuberculosis. Indian J Dermatol Venereol Leprol 2003;69:428-9

How to cite this URL:
Rao L, Padmavathy L. Utility of MycoDot test in the diagnosis of cutaneous tuberculosis. Indian J Dermatol Venereol Leprol [serial online] 2003 [cited 2020 Sep 20];69:428-9. Available from:

Mycobacteria are known to have several immunologically active antigenic components like 38 Kd antigen, 30 Kd antigen, 16 Kd antigen, A60 antigen and lipoarabinomannan (LAM).[1] The MycoDot test is a new simple, rapid (20 minutes) and reliable serodiagnostic technique that can detect anti-mycobacterial antibodies in the serum or blood. It offers a low cost, single visit aid in the diagnosis of tuberculosis, with good sensitivity and excellent specificity.

The MycoDot test employs lipoarabinomannan (LAM) antigen which is bound to plastic combs. When the combs are incubated in diluted serum/blood, specific anti-LAM antibodies from the sample, if present, bind to the antigen. The sensitivity of the test is calibrated so that only cases of active mycobacterial diseases such as tuberculosis will generate a colored spot, which is as strong as or stronger than the weakest positive spot on the reference comb that is provided as a guide to interpret results. Healthy infected and/or BCG vaccinated individuals react negatively.

We studied the utility of the MycoDot test in cutaneous tuberculosis by using it to screen the sera of 22 randomly selected patients with cutaneous tuberculosis from 117 cases of cutaneous tuberculosis for the presence of anti-mycobacterial antibodies. All the patients were subjected to routine laboratory investigations and skin biopsy, which revealed epithelioid granulomas. All cases were negative for AFB both in tissue smears and in culture. Of the 22 cases 7 had scrofuloderma, 4 lupus vulgaris, 8 tuberculosis verrucosa cutis, 2 had combination of tuberculosis verrucosa cutis and lupus vulgaris and one patient had erythema nodosum suspected to be due to tuberculosis. All our patients responded well to standard anti-tuberculous treatment.

Out of a total of 22 specimens, the sera from 9 patients tested positive, i.e. 40.8% positivity. The efficacy of the test was 47.8%, and the sensitivity was 43.4%. The negative predictive value was only 7.1%. Hence a positive test is of significance while a negative result does not necessarily rule out tuberculosis.

In Mexico the sensitivity of an ELISA test for IgG antibody to LAM used for the serodiagnosis of tuberculosis was 75% in patients with tuberculosis.[2] ELISA with LAM was also used to detect IgG in the cerebrospinal fluid of patients with tuberculous meningitis.[3] The positivity was 85% and the sensitivity and specificity were 26-81% and 92-100% respectively.

In primary tuberculosis, progression is accompanied by an increase of the antibody titer and healing by a decrease. In secondary tuberculosis, the IgG antibody levels do not return to normal in a fraction of patients. The presence of antibodies merely indicates a past or present mycobacterial infection. However, it has been reported that the presence of antibodies of the IgG type requires the presence of antigen, in the form of active tuberculosis.[4] Hence seropositivity indicates that the disease process is still active in these patients, in the form of antigens being liberated from degenerating bacilli.

Serodiagnosis is not a substitute for clinical examination and histopathology, but only an adjunct in the diagnosis of cutaneous tuberculosis. However, serodiagnosis by the Mycodot test is not adequately sensitive to be useful for screening patients for cutaneous tuberculosis. 

      References Top

1.Nassau E, Parsons ER, Johnson GD, Parsons ER. The detection of antibodies to Mycobacterium tuberculosis by microplate enzyme linked immunosorbent assay (ELISA). Tubercle 1976;57:67-70.  Back to cited text no. 1    
2.Sada E, Aguilar D, Torres M, Herrera T. Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Microbiol 1992;30:2415-8.   Back to cited text no. 2  [PUBMED]  
3.Park SC, Lee BI, Cho SN, et al. Diagnosis of tuberculosis by detection of IgG antibodies to purified protein derivatives and LAM antigen in CSF. Tuberc Lung Dis 1993;74:317-22.  Back to cited text no. 3  [PUBMED]  
4.Thomas DM. Immunodiagnosis of tuberculosis. In: Rom W, Garay S, editors. Tuberculosis. 1st ed. London: Little Brown and Co; 1996. p. 223- 31.   Back to cited text no. 4    
5.Kardjito T, Grange JM. Diagnosis of active tuberculosis by immunological methods. 2. Qualitative differences in the dermal response to tuberculin in patients with active pulmonary disease and healthy tuberculin positive individuals. Tubercle 1982;63:275-8.  Back to cited text no. 5  [PUBMED]  


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow